NR1H4 and cholestasis: Parenteral nutrition-induced cholestasis disrupts bile acid-mediated activation of intestinal FXR-FGF19 signaling and we showed that treatment with enteral chenodeoxycholic acid (CDCA) restored FGF19 secretion and reduced serum cholestasis in neonatal pigs14.